Literature DB >> 32870387

Trends in the prevalence of kidney stones in the United States from 2007 to 2016.

Api Chewcharat1,2, Gary Curhan3,4.   

Abstract

The overall prevalence of kidney stones (KS) in the US rose from 3.2% in 1980 to 10.1% in 2016, but the trends in important subgroups have not been reported. We examined the prevalence trends of KS in subgroups of age, sex and race in the US and identified relevant laboratory factors associated with a history of KS using National Health and Nutrition Examination Survey (NHANES) data. We conducted a cross-sectional study among 28,209 US adults aged ≥ 20 years old in the NHANES from 2007 to 2016. We calculated the prevalence of a self-reported history of KS by using weights and standardized to the 2010 US Census population. We also compared relevant laboratory values according to the history of KS. The prevalence of KS decreased from 8.7% in 2007-2008 to 7.2% in 2011-2012 but then increased to 9.0% in 2013-2014 and 10.1% in 2015-2016. However, the overall prevalence of KS increased over 2007-2016 (p-trend = 0.02). Prevalence of KS among men was higher than women. Among men aged 20-79, there were significant quadratic trends in the prevalence of KS. Whereas, the prevalence of KS increased as a linear trend among women aged 20-59 years over 2007-2016. There were no consistent trends in the prevalence of KS by race. The prevalence trend of KS among non-Hispanic whites was 9.8% from 2007 to 2010 then dropped to 7.9% in 2011-2012 and increased to 10.6% in 2013-2014 and 12.1% in 2015-2016. A similar trend was also observed among non-Hispanic blacks. Among Hispanic, the prevalence of KS was 7.6% in 2007-2008 and 7.4% in 2009-2010 and then fluctuated over the next several time periods. For non-Hispanic Asians, the range was 4.4-4.6%. Regarding relevant laboratory factors, after adjusting for sex, race, age, BMI, smoking status, alcohol drinking, history of diabetes and gout, urine albumin-creatinine ratio and serum osmolality were independently associated with the history of KS in women and men. In conclusion, there was substantial variability in KS prevalence across individual 2-year time periods. This variation of period-specific prevalence values emphasizes the importance of looking at long-term trends and using more than a single 2-year cycle in analyses to increase the precision of the estimate. However, there was an overall increase in the prevalence of KS over 2007-2016.

Entities:  

Keywords:  Kidney stone; NHANES; Nephrolithiasis; Prevalence; Trends

Mesh:

Year:  2020        PMID: 32870387     DOI: 10.1007/s00240-020-01210-w

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  49 in total

1.  Kidney stones: a global picture of prevalence, incidence, and associated risk factors.

Authors:  Victoriano Romero; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

2.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.

Authors:  Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver
Journal:  J Clin Endocrinol Metab       Date:  2011-06-06       Impact factor: 5.958

3.  Uric acid stones increase the risk of chronic kidney disease.

Authors:  Ching-Chia Li; Tsu-Ming Chien; Wen-Jeng Wu; Chun-Nung Huang; Yii-Her Chou
Journal:  Urolithiasis       Date:  2018-02-28       Impact factor: 3.436

4.  Kidney stones and cardiovascular events: a cohort study.

Authors:  R Todd Alexander; Brenda R Hemmelgarn; Natasha Wiebe; Aminu Bello; Susan Samuel; Scott W Klarenbach; Gary C Curhan; Marcello Tonelli
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 8.237

Review 5.  Chronic kidney disease in kidney stone formers.

Authors:  Andrew D Rule; Amy E Krambeck; John C Lieske
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

6.  Urolithiasis and the risk of ESRD.

Authors:  Ziad M El-Zoghby; John C Lieske; Robert N Foley; Eric J Bergstralh; Xujian Li; L Joseph Melton; Amy E Krambeck; Andrew D Rule
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-28       Impact factor: 8.237

7.  Nephrolithiasis and Risk of Incident Bone Fracture.

Authors:  Eric N Taylor; Diane Feskanich; Julie M Paik; Gary C Curhan
Journal:  J Urol       Date:  2015-12-18       Impact factor: 7.450

8.  The Risk of Coronary Heart Disease in Patients with Kidney Stones: A Systematic Review and Meta-analysis.

Authors:  Wisit Cheungpasitporn; Charat Thongprayoon; Michael A Mao; Oisin A O'Corragain; Peter J Edmonds; Stephen B Erickson
Journal:  N Am J Med Sci       Date:  2014-11

Review 9.  Kidney Stone Disease: An Update on Current Concepts.

Authors:  Tilahun Alelign; Beyene Petros
Journal:  Adv Urol       Date:  2018-02-04

Review 10.  Economic impact of urinary stones.

Authors:  Elias S Hyams; Brian R Matlaga
Journal:  Transl Androl Urol       Date:  2014-09
View more
  11 in total

1.  Urolithiasis in Germany: Trends from the National DRG Database.

Authors:  Hendrik Heers; David Stay; Thomas Wiesmann; Rainer Hofmann
Journal:  Urol Int       Date:  2021-12-09       Impact factor: 1.934

2.  Baseline urine pH is related to effective urine alkalization by short-term alkaline water supplementation: data from a self-controlled study in healthy Chinese volunteers following a systematic review and meta-analysis of literature.

Authors:  Guanghan Zhang; Tuo Deng; Ruiqi Deng; Xinyuan Sun; Yinghua He; Zezhen Liu
Journal:  Transl Androl Urol       Date:  2022-05

3.  Standardization of microbiome studies for urolithiasis: an international consensus agreement.

Authors:  Naveen Kachroo; Dirk Lange; Kristina L Penniston; Joshua Stern; Gregory Tasian; Petar Bajic; Alan J Wolfe; Mangesh Suryavanshi; Andrea Ticinesi; Tiziana Meschi; Manoj Monga; Aaron W Miller
Journal:  Nat Rev Urol       Date:  2021-03-29       Impact factor: 14.432

4.  Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis.

Authors:  Kai Wang; Jing Ge; Wenlong Han; Dong Wang; Yinjuan Zhao; Yanhao Shen; Jiexun Chen; Dongming Chen; Jing Wu; Ning Shen; Shuai Zhu; Bin Xue; Xianlin Xu
Journal:  BMC Urol       Date:  2022-04-19       Impact factor: 2.090

5.  Roles of heat-shock protein 90 and its four domains (N, LR, M and C) in calcium oxalate stone-forming processes.

Authors:  Sunisa Yoodee; Paleerath Peerapen; Sirikanya Plumworasawat; Visith Thongboonkerd
Journal:  Cell Mol Life Sci       Date:  2022-07-28       Impact factor: 9.207

Review 6.  Nutrition and Kidney Stone Disease.

Authors:  Roswitha Siener
Journal:  Nutrients       Date:  2021-06-03       Impact factor: 5.717

7.  Effect of Black Tea Consumption on Urinary Risk Factors for Kidney Stone Formation.

Authors:  Roswitha Siener; Albrecht Hesse
Journal:  Nutrients       Date:  2021-12-11       Impact factor: 5.717

Review 8.  Comparison of Ultra-Mini Percutaneous Nephrolithotomy and Retrograde Intrarenal Surgery for Renal Stones: A Systematic Review and Meta-Analysis from the KSER Update Series.

Authors:  Hae Do Jung; Doo Yong Chung; Do Kyung Kim; Min Ho Lee; Sin Woo Lee; Sunghyun Paick; Seung Hyun Jeon; Joo Yong Lee
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

9.  Application of Clavien-Dindo Classification System for Complications of Minimally Invasive Percutaneous Nephrolithotomy.

Authors:  Xiao-Jun Zhang; Zheng-Jie Zhu; Jun-Jie Wu
Journal:  J Healthc Eng       Date:  2021-12-15       Impact factor: 2.682

10.  Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults.

Authors:  Makinna C Oestreich; Robin Wm Vernooij; Niranjan J Sathianathen; Eu Chang Hwang; Gretchen M Kuntz; Alex Koziarz; Charles D Scales; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2020-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.